Microsoft stock jumped Friday — what investors watch before MSFT earnings next week

Microsoft Corp shares climbed roughly 0.7% to $459.86 in early New York trading Tuesday after Bristol Myers Squibb announced a deal to deploy the software giant’s AI-powered radiology tools aimed at accelerating early lung cancer detection. The partnership will leverage U.S. Food and Drug Administration-cleared imaging algorithms—approved for clinical use—via Microsoft’s Precision Imaging Network, which already analyzes X-ray and CT scans at hospitals across the U.S. “We have envisioned a unique AI-enabled workflow” to help clinicians identify patients and direct them to care, said Alexandra Goncalves, vice president and head of digital health at Bristol Myers.

Elon Musk is pursuing up to $134 billion from OpenAI and Microsoft Corp, alleging they reaped “wrongful gains” from his early investment in the AI lab, according to a federal court filing. OpenAI dismissed the lawsuit as “unserious,” while Microsoft declined to comment. Microsoft shares closed Friday up 0.7% at $459.86.

Microsoft shares dropped 2.6% on Wednesday, deepening a retreat in mega-cap tech amid investor concerns over the escalating expenses — and political hurdles — tied to building new AI data centers. The stock lost $12.17 to close at $458.50 in late U.S. trading. Meanwhile, the Invesco QQQ fell 1.3%, and the SPDR S&P 500 ETF slipped 0.7%.